Literature DB >> 29182323

Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses.

Antonella Ciancetta1, Robert D O'Connor1, Silvia Paoletta1, Kenneth A Jacobson1.   

Abstract

We performed a molecular modeling analysis of 100 nucleotide-like bisphosphates and 46 non-nucleotide arylurea derivatives previously reported as P2Y1R binders using the recently solved hP2Y1R structures. We initially docked the compounds at the X-ray structures and identified the binding modes of representative compounds highlighting key patterns in the structure-activity relationship (SAR). We subsequently subjected receptor complexes with selected key agonists (2MeSADP and MRS2268) and antagonists (MRS2500 and BPTU) to membrane molecular dynamics (MD) simulations (at least 200 ns run in triplicate, simulation time 0.6-1.6 μs per ligand system) while considering alternative protonation states of nucleotides. Comparing the temporal evolution of the ligand-protein interaction patterns with available site-directed mutagenesis (SDM) data and P2Y1R apo state simulation provided further SAR insights and suggested reasonable explanations for loss/gain of binding affinity as well as the most relevant charged species for nucleotide ligands. The MD analysis also predicted local conformational changes required for the receptor inactive state to accommodate nucleotide agonists.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29182323      PMCID: PMC5953180          DOI: 10.1021/acs.jcim.7b00528

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  59 in total

1.  P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoring.

Authors:  Stefano Costanzi; Irina G Tikhonova; Michihiro Ohno; Eun Joo Roh; Bhalchandra V Joshi; Anny-Odile Colson; Dayle Houston; Savitri Maddileti; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2007-06-12       Impact factor: 7.446

2.  Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges.

Authors:  K Vanommeslaeghe; E Prabhu Raman; A D MacKerell
Journal:  J Chem Inf Model       Date:  2012-11-28       Impact factor: 4.956

3.  Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.

Authors:  E Camaioni; J L Boyer; A Mohanram; T K Harden; K A Jacobson
Journal:  J Med Chem       Date:  1998-01-15       Impact factor: 7.446

4.  Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior.

Authors:  Sacha A Malin; Derek C Molliver
Journal:  Mol Pain       Date:  2010-04-15       Impact factor: 3.395

5.  Structure Activity Relationships for Derivatives of Adenosine-5'-Triphosphate as Agonists at P(2) Purinoceptors: Heterogeneity Within P(2X) and P(2Y) Subtypes.

Authors:  Geoffrey Burnstock; Bilha Fischer; Charles H V Hoyle; Michel Maillard; Airat U Ziganshin; Antonia L Brizzolara; Amy von Isakovics; José L Boyer; T Kendall Harden; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  2004-10-05       Impact factor: 4.360

6.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

7.  Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists.

Authors:  Angel I Morales-Ramos; John S Mecom; Terry J Kiesow; Todd L Graybill; Gregory D Brown; Nambi V Aiyar; Elizabeth A Davenport; Lorena A Kallal; Beth A Knapp-Reed; Peng Li; Allyn T Londregan; Dwight M Morrow; Shobha Senadhi; Reema K Thalji; Steve Zhao; Cynthia L Burns-Kurtis; Joseph P Marino
Journal:  Bioorg Med Chem Lett       Date:  2008-10-02       Impact factor: 2.823

8.  Autocrine activation of P2Y1 receptors couples Ca (2+) influx to Ca (2+) release in human pancreatic beta cells.

Authors:  Shara Khan; Richard Yan-Do; Eric Duong; Xichen Wu; Austin Bautista; Stephen Cheley; Patrick E MacDonald; Matthias Braun
Journal:  Diabetologia       Date:  2014-09-11       Impact factor: 10.122

9.  New azole antagonists with high affinity for the P2Y(1) receptor.

Authors:  Réjean Ruel; Alexandre L'Heureux; Carl Thibeault; Jean-Paul Daris; Alain Martel; Laura A Price; Qimin Wu; Ji Hua; Ruth R Wexler; Robert Rehfuss; Patrick Y S Lam
Journal:  Bioorg Med Chem Lett       Date:  2013-04-25       Impact factor: 2.823

10.  2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.

Authors:  Hak Sung Kim; Michihiro Ohno; Bin Xu; Hea Ok Kim; Yongseok Choi; Xiao D Ji; Savitri Maddileti; Victor E Marquez; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2003-11-06       Impact factor: 7.446

View more
  9 in total

Review 1.  Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.

Authors:  Kenneth A Jacobson; Veronica Salmaso; R Rama Suresh; Dilip K Tosh
Journal:  RSC Med Chem       Date:  2021-07-13

2.  Nucleotide P2Y1 receptor agonists are in vitro and in vivo prodrugs of A1/A3 adenosine receptor agonists: implications for roles of P2Y1 and A1/A3 receptors in physiology and pathology.

Authors:  Theodore E Liston; Sonja Hinz; Christa E Müller; Deborah M Holstein; Jay Wendling; Roger J Melton; Mary Campbell; William S Korinek; R Rama Suresh; Dane A Sethre-Hofstad; Zhan-Guo Gao; Dilip K Tosh; Kenneth A Jacobson; James D Lechleiter
Journal:  Purinergic Signal       Date:  2020-10-31       Impact factor: 3.765

3.  A3 adenosine receptor activation mechanisms: molecular dynamics analysis of inactive, active, and fully active states.

Authors:  Antonella Ciancetta; Priscila Rubio; David I Lieberman; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2019-11-22       Impact factor: 3.686

Review 4.  Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.

Authors:  Veronica Salmaso; Kenneth A Jacobson
Journal:  ChemMedChem       Date:  2020-09-18       Impact factor: 3.540

5.  Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18.

Authors:  Alexander Neumann; Viktor Engel; Andhika B Mahardhika; Clara T Schoeder; Vigneshwaran Namasivayam; Katarzyna Kieć-Kononowicz; Christa E Müller
Journal:  Biomolecules       Date:  2020-04-29

6.  Mapping the Binding Sites of UDP and Prostaglandin E2 Glyceryl Ester in the Nucleotide Receptor P2Y6.

Authors:  Anne Zimmermann; Oanh Vu; Antje Brüser; Gregory Sliwoski; Lawrence J Marnett; Jens Meiler; Torsten Schöneberg
Journal:  ChemMedChem       Date:  2022-01-28       Impact factor: 3.540

7.  Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations.

Authors:  Tianyi Ding; Dmitry S Karlov; Almudena Pino-Angeles; Irina G Tikhonova
Journal:  J Chem Inf Model       Date:  2022-09-30       Impact factor: 6.162

Review 8.  In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors.

Authors:  Veronica Salmaso; Kenneth A Jacobson
Journal:  Biomolecules       Date:  2020-05-26

9.  Tumour necrosis factor-α promotes BMHSC differentiation by increasing P2X7 receptor in oestrogen-deficient osteoporosis.

Authors:  Jiajia Lu; Zhibin Zhou; Jun Ma; Nan Lu; Zhu Lei; Di Du; Aimin Chen
Journal:  J Cell Mol Med       Date:  2020-11-09       Impact factor: 5.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.